Remdesivir most promising COVID-19 drug, say researchers
A review of potential COVID-19 therapeutics revealed that the most effective are likely to be those directly targeting SARS-CoV-2, such as remdesivir and tilarone.
List view / Grid view
A review of potential COVID-19 therapeutics revealed that the most effective are likely to be those directly targeting SARS-CoV-2, such as remdesivir and tilarone.
Researchers have imaged an inflammation-related protein receptor on cell membranes which could inform future drug designs to prevent cell death.
Using data collected from the UK, the data suggests that up to 25 million people in the US may be at more than triple the risk of coronary artery disease...
Researchers have found that patients who receive cardiac PET imaging instead of SPECT experienced a significant increase in the detection of severe obstructive coronary artery disease...
Researchers have identified a possible genetic basis for coronary artery disease...
Researchers have indicated that high levels of a thyroid hormone FT4, are associated with coronary artery disease...
A new gene therapy that targets the heart and requires only one treatment session has been found safe for patients with coronary artery disease...